Clovis Oncology to Present at the 36th Annual J.P. Morgan Healthcare Conference

[End Subhead]
[Start Distributor]
Business Wire 4-Jan-2018 8:00 AM
[End Distributor]
BOULDER, Colo.--(BUSINESS WIRE)-- Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that its Chief Executive Officer and President, Patrick J. Mahaffy, will present at the 36th Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2018 at 2:30 PM Pacific Time. The conference will be held at the Westin St. Francis Hotel in San Francisco.
A live webcast of the presentation and breakout session can be accessed through the investor relations section of the Companys website at www.clovisoncology.com. Following the live presentation, a replay of the webcast will be available on the Companys website for 30 days.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops, with partners, diagnostic tools intended to direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado, and has additional offices in San Francisco, California and Cambridge, UK. Please visit www.clovisoncology.com for more information.

View source version on businesswire.com: http://www.businesswire.com/news/home/20180104005327/en/
Clovis Oncology, Inc. Anna Sussman, 303-625-5022asussman@clovisoncology.comorBreanna Burkart, 303-625-5023bburkart@clovisoncology.com
Source: Clovis Oncology, Inc.